Positron emission tomography for radiation treatment planning. - Wikidata - awgldk - TriplyDB

Positron emission tomography for radiation treatment planning.

Positron emission tomography for radiation treatment planning.

http://www.wikidata.org/entity/Q30996584

about

The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia.The role of imaging in radiation therapy planning: past, present, and future Magnetic resonance perfusion imaging in neuro-oncology.Influence of rigid coregistration of PET and CT data on metabolic volumetry: a user's perspective Recent advances in radiotherapy.Molecular imaging of gliomas with PET: opportunities and limitations.Magnetic resonance imaging for adaptive cobalt tomotherapy: A proposal.Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patients Functional and molecular image guidance in radiotherapy treatment planning optimization.Update on clinical radiobiology The future of hybrid imaging-part 2: PET/CT.Influence of different treatment techniques on radiation dose to the LAD coronary artery Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.From anatomical to biological target volumes: the role of PET in radiation treatment planning Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer.Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme.Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical Settings PET/CT imaging to guide cervical cancer therapy.Technological advances in radiotherapy for esophageal cancer Highly cited German research contributions to the fields of radiation oncology, biology, and physics: focus on collaboration and diversity.Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients - A Review.Current advances in radiotherapy of head and neck malignancies.Choline PET based dose-painting in prostate cancer--modelling of dose effects Validation of automatic target volume definition as demonstrated for 11C-choline PET/CT of human prostate cancer using multi-modality fusion techniques Intensity-modulated radiotherapy for the treatment of pelvic lymph nodes in prostate cancer.Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study Usefulness of positron emission tomographic studies for gliomas.[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes.Nonrigid image registration for head and neck cancer radiotherapy treatment planning with PET/CT.Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer.Comparison between 2-(18) F-fluoro-2-deoxy-d-glucose positron emission tomography and contrast-enhanced computed tomography for measuring gross tumor volume in cats with oral squamous cell carcinoma.Tumor image signatures and habitats: a processing pipeline of multimodality metabolic and physiological images.11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer.A Network Meta-Analysis on the Diagnostic Value of Different Imaging Methods for Lymph Node Metastases in Patients With Cervical Cancer.(68)Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : Early efficacy after primary therapy.

P2860

Q27025579-BEE8CF7F-99E5-4A41-813A-0D0BD69547B6 Q27334035-FCAE5834-1ED0-4216-AEE0-FB0590F9C82D Q28239750-152CB7C5-22E6-4C60-B33E-84D63D240C44 Q30479156-44A0239D-B72D-462D-B191-C41A776B1C87 Q30724225-424A0FA6-BEC5-4309-8AAE-C038149ABDAF Q33567305-0C8C54D5-0D54-4E7C-84AC-5B6EFBCB2399 Q33961188-E2D86CE0-709E-41B9-9E81-8C9335713724 Q34415525-797B869A-7E4B-466A-B925-3D00818ED691 Q34533978-3890A858-A96D-455D-8B43-887A9ABA7305 Q34706820-C047C511-B027-4331-8950-5EEBEC61B8E8 Q34991321-DB421D61-44B2-4A88-9F23-0DA626AAB6DA Q35786046-43B1659C-F69B-40FD-AA5A-23A1DD4E57A7 Q35842373-145109CA-1376-403A-B10B-D121F5A97DD7 Q36325435-6B550111-1B57-4A9A-B0E5-0B042D5034A0 Q36343896-8AF7170F-0E3A-48CE-A69C-D0A81FDF1E32 Q36657385-2FA4627F-9620-462F-BD2E-9654A38D2CEA Q37006913-C907CC2F-4BAE-40B3-BC5D-7DDE49E14B81 Q37119526-CEF1F699-1DDD-4D3F-BCEE-90A1FAFD16B6 Q37604088-B19A879F-F50C-48CE-BA71-9163A07D6437 Q37605851-F93A02C6-A482-4DE6-A551-5F0A31414576 Q37812088-B87E6E55-EE9F-4F7E-B1CF-E410242BC881 Q38036587-1C2769E9-76B2-495C-9646-88F55A454154 Q38051641-92C7A99D-FE6B-4E14-957D-2EA1B53F44A1 Q38181048-75BBB38F-1B84-4C40-B282-1EEDB13508CB Q38445916-16DDEA64-C70D-4035-A576-F470774AAEFC Q40010576-CE20C67F-6BC9-4C6B-8358-1FDA91E84703 Q40244947-7D1B8C1F-3D32-4E88-BB09-106348D8C240 Q41195176-2463BC7C-C591-46B5-9333-BEC14ADBBBD7 Q41965733-9BDFCBDF-7031-461C-A770-C9858F0655D8 Q42072377-0F9CBEF4-886B-4CA9-9545-ECEF50117B1D Q42122701-6BE54172-D6B1-4166-83B1-B69931302DDA Q43287327-053293DC-E152-4BE3-9E76-CAECD4E8CEFA Q44322324-C683A557-8D0D-4F68-B553-6F10A01BF54D Q45119742-6E1AD55F-2DC4-4AC9-878C-3C0E04614041 Q45732944-AF000F8C-46D2-4C0E-B9D2-C723E3E22B57 Q47308505-6D04A480-AC06-493D-90C4-A20FC7C13A28 Q47693880-AF730481-E12B-4055-B86D-13880A08D443 Q49464271-5306EC9E-FDD5-460F-BDE3-663DF3680D11 Q51715242-5C597278-7F5B-40EE-8760-9F09FC54D377

P2860

Positron emission tomography for radiation treatment planning.

http://www.wikidata.org/entity/Q30996584

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Positron emission tomography for radiation treatment planning.

@ast

Positron emission tomography for radiation treatment planning.

@en

type

label

Positron emission tomography for radiation treatment planning.

@ast

Positron emission tomography for radiation treatment planning.

@en

prefLabel

Positron emission tomography for radiation treatment planning.

@ast

Positron emission tomography for radiation treatment planning.

@en

P1433

Q30996584-21B39BBE-E9FF-49BD-96F2-7688B8DFE8A3

P1476

Q30996584-FCB041BC-1165-49C1-9F35-BBE04DD0C88F

P2093

Q30996584-604AF467-43A3-4FBD-B4F6-C0EB49D65345

Q30996584-715F4F89-FC54-4FE4-B435-87DE77341605

Q30996584-7F5FE106-D0BA-46F6-8E64-420A1BD30336

Q30996584-93F448CD-E630-464F-A61F-FC61A51087F0

Q30996584-BB649C0C-E039-41F3-AF1E-93E7021CC415

Q30996584-C1082372-565F-4EFF-BC43-DAE5E1EFA0AC

Q30996584-CF773305-266F-4318-80A1-7BBC28917F8F

P2888

Q30996584-0FD20F20-F8BC-420C-B8F9-717EA6237644

P304

Q30996584-5EA38D63-7352-49E0-8936-7722932521AA

P31

Q30996584-2BF96BC7-FA04-4806-A28E-1F330F370892

P356

Q30996584-4E5B4479-148F-44C8-B290-C1ADD9EEB112

P433

Q30996584-0ECA898D-E72F-4E89-8F13-8C3B627653C1

P478

Q30996584-F6B8830F-502F-4EE3-A2AD-EE17C49E6E15

P50

Q30996584-3040D09A-F9DC-42A0-BD3C-10327F38DE03

Q30996584-B8717E7E-484B-4F32-94C5-9403757BAB29

P577

Q30996584-AA9C7F4A-34B2-4532-A907-CE78C0FE423A

P6179

Q30996584-2EAF2D69-2A2E-464A-9BE6-525F03F53C5A

P698

Q30996584-E783D36A-8874-4855-A7B0-8EF38E107498

P356

S00066-005-1422-7

P1433

Strahlentherapie und Onkologie

P1476

Positron emission tomography for radiation treatment planning.

@en

P2093

Anca-Ligia Grosu

http://www.w3.org/2001/XMLSchema#string

Branislav Jeremic

http://www.w3.org/2001/XMLSchema#string

Frank B Zimmermann

http://www.w3.org/2001/XMLSchema#string

Michael Molls

http://www.w3.org/2001/XMLSchema#string

Morand Piert

http://www.w3.org/2001/XMLSchema#string

Ulrich Schratzenstaller

http://www.w3.org/2001/XMLSchema#string

Wolfgang A Weber

http://www.w3.org/2001/XMLSchema#string

P2888

s00066-005-1422-7

P304

483-499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00066-005-1422-7

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P50

Markus Schwaiger

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1031999593

http://www.w3.org/2001/XMLSchema#string

P698

16044216

http://www.w3.org/2001/XMLSchema#string